Skip to content

Clinical Comparison of Two Daily Disposable Toric Soft Contact Lenses

Clinical Comparison of Two Daily Disposable Toric Soft Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05483127
Enrollment
153
Registered
2022-08-01
Start date
2022-09-13
Completion date
2022-10-31
Last updated
2023-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ametropia, Astigmatism, Myopia

Keywords

Contact lenses, Vision, Eye sight

Brief summary

The primary purpose of this study is to demonstrate noninferiority in the visual acuity at distance when wearing PRECISION1™ for Astigmatism (P1fA) soft contact lenses compared to another commercially available, soft toric contact lens, MyDay® toric (MDT).

Detailed description

Study participants will wear each study lens type in 1 of 2 randomized, crossover sequences. Participants will be expected to attend 4 visits and wear study lenses for at least 10 hours per day. The total duration of an individual's participation in the study will be up to 28 days.

Interventions

Soft contact lenses for optical correction of ametropia and astigmatism

DEVICEStenfilcon A toric soft contact lenses

Soft contact lenses for optical correction of ametropia and astigmatism

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Successful wearers of toric soft contact lenses in both eyes with at least 3 months wearing experience, with a minimum wearing time of 5 days per week and 10 hours per day. * Able to wear contact lenses within a range of sphere & cylinder power and axes. * Willing to NOT use rewetting/lubricating drops at any time during the study. * Other protocol-defined inclusion criteria may apply. Key

Exclusion criteria

* Current or previous P1fA and MDT habitual lens wearers. * Monovision and multifocal lens wearers. * Participation of the subject in a clinical trial within the previous 30 days or currently enrolled in any clinical trial. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Least Squares Means Distance Visual Acuity With Study Lenses at Week 1Day 8 of each study lens type worn during the corresponding crossover periodDistance visual acuity (VA) was assessed with study lenses in place. VA was collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. LogMAR typically ranges from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision). A logMAR acuity of 0.0 corresponds to 20/20 Snellen (normal distance visual acuity), with a negative value denoting better than 20/20 visual acuity.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from 11 investigative sites located in the United States.

Pre-assignment details

Of the 153 enrolled, 1 participant was exited prior to randomization as a screen failure. This reporting group includes all randomized participants (152).

Participants by arm

ArmCount
P1fA, Then MDT
Verofilcon A toric soft contact lenses worn first, followed by stenfilcon A toric soft contact lenses, as randomized. Each study lens type was worn for 8 (-0/+3) days for at least 10 hours per day. Lenses were removed nightly and disposed of after a single use.
77
MDT, Then P1fA
Stenfilcon A toric soft contact lenses worn first, followed by verofilcon A toric soft contact lenses, as randomized. Each study lens type was worn for 8 (-0/+3) days for at least 10 hours per day. Lenses were removed nightly and disposed of after a single use.
75
Total152

Baseline characteristics

CharacteristicMDT, Then P1fATotalP1fA, Then MDT
Age, Continuous34.3 years
STANDARD_DEVIATION 8.6
34.4 years
STANDARD_DEVIATION 9
34.6 years
STANDARD_DEVIATION 9.4
Ethnicity (NIH/OMB)
Hispanic or Latino
9 Participants21 Participants12 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
66 Participants131 Participants65 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Asian
4 Participants8 Participants4 Participants
Race/Ethnicity, Customized
Black or African American
5 Participants10 Participants5 Participants
Race/Ethnicity, Customized
Multi-Racial
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Other
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
White
66 Participants132 Participants66 Participants
Region of Enrollment
United States
75 participants152 participants77 participants
Sex: Female, Male
Female
46 Participants94 Participants48 Participants
Sex: Female, Male
Male
29 Participants58 Participants29 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
0 / 1520 / 3040 / 1520 / 3020 / 151
other
Total, other adverse events
0 / 1520 / 3040 / 1520 / 3020 / 151
serious
Total, serious adverse events
0 / 1520 / 3040 / 1520 / 3020 / 151

Outcome results

Primary

Least Squares Means Distance Visual Acuity With Study Lenses at Week 1

Distance visual acuity (VA) was assessed with study lenses in place. VA was collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. LogMAR typically ranges from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision). A logMAR acuity of 0.0 corresponds to 20/20 Snellen (normal distance visual acuity), with a negative value denoting better than 20/20 visual acuity.

Time frame: Day 8 of each study lens type worn during the corresponding crossover period

Population: Full Analysis Set with data at visit.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
PRECISION1 for Astigmatism (P1fA)Least Squares Means Distance Visual Acuity With Study Lenses at Week 1-0.11 logMARStandard Error 0.005
MyDay Toric (MDT)Least Squares Means Distance Visual Acuity With Study Lenses at Week 1-0.10 logMARStandard Error 0.005

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026